Discussions during the meeting focused on strengthening India’s preparedness against zoonotic diseases and climate-sensitive health challenges
Doshi has established a strong track record in driving quality assurance, regulatory compliance, and formulation excellence across complex pharmaceutical operations
The global pharmaceutical company has been featured in both the DJBIC World Index and the DJBIC Emerging Markets Index
Access to genomic testing, not therapy cost, is the biggest challenge
The company also confirmed that ABS-1230 has been accepted into the U.S. Food and Drug Administration’s Rare Disease Evidence Principles (RDEP) process
IIT Kanpur team has developed computational framework to map how cell signals influence gene activity across tissues
India’s institutions now need to upgrade TTOs as strategic innovation units rather than administrative support cells
These check-ups will be conducted through ESIC’s extensive network of hospitals, with a focus on early diagnosis, preventive healthcare, and continuous health monitoring
With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical
Subscribe To Our Newsletter & Stay Updated
